HRT Financial’s Thermo Fisher Scientific TMO Stock Holding History

HRT Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.9M	Buy	+24,300	New	+$13.2M	0.03%	552
2023 Q4	–	Sell	-1,900	Closed	-$961K	–	3083
2023 Q3	$961K	Buy	+1,900	New	+$1.01M	0.01%	1002
2023 Q2	–	Sell	-900	Closed	-$518K	–	3277
2023 Q1	$518K	Sell	900 -300	-25%	-$169K	0.01%	1354
2022 Q4	$660K	Buy	1,200 +300	+33%	+$159K	0.01%	1232
2022 Q3	$456K	Buy	+900	New	+$504K	﹤0.01%	1697

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HRT Financial's TMO Position: Q1 2026 in Review

HRT Financial opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 554 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #2955 among its holdings. This is a return to the name: HRT Financial previously reported a position in TMO as recently as Q3 2025.

HRT Financial first reported a position in TMO in Q3 2019 and has held it in 16 quarters since. The position peaked at $86.2M in Q2 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

HRT Financial held 554 shares of Thermo Fisher Scientific worth $272K as of Q1 2026.
Thermo Fisher Scientific was a new HRT Financial position in Q1 2026.
Thermo Fisher Scientific made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2955 holding.
HRT Financial first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 16 quarters since.
HRT Financial's Thermo Fisher Scientific position peaked at $86.2M in Q2 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.